EKF Diagnostics Investor Announcements

EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

Capitalised terms in this announcement carry the same meaning as in the RNS of 28 September 2021, unless otherwise stated

5th Oct 2021

Texas based CLIA lab acquired, specialising in COVID-19 PCR testing.

14th Sep 2021

Further upgrade to current year trading.

25th Aug 2021

Investor briefing.

21st Jul 2021

Full year performance expected to be in-line with management expectations.

16th Jun 2021

Appointment of Investec Bank plc as joint corporate broker, with immediate effect to work alongside its existing nominated adviser and broker, N+1 Singer.

7th Jun 2021

Presentation to institutional investors by Julian Baines and Mike Salter.

Update on Fundraising and Admission by Trellus Health.

Launch of Restricted Offer on behalf of Trellus Health.